| Year |
Citation |
Score |
| 2024 |
Garbuzenko OB, Sapiezynski J, Girda E, Rodriguez-Rodriguez L, Minko T. Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer. Small (Weinheim An Der Bergstrasse, Germany). e2307462. PMID 38342698 DOI: 10.1002/smll.202307462 |
0.313 |
|
| 2021 |
Majumder J, Minko T. Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations. Pharmaceutics. 13. PMID 34371754 DOI: 10.3390/pharmaceutics13071063 |
0.388 |
|
| 2020 |
Majumder J, Minko T. Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus. Advanced Therapeutics. 2000203. PMID 33173809 DOI: 10.1002/adtp.202000203 |
0.352 |
|
| 2020 |
Majumder J, Minko T. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery. Expert Opinion On Drug Delivery. PMID 32969740 DOI: 10.1080/17425247.2021.1828339 |
0.364 |
|
| 2020 |
Minko T. Nanoformulation of BRD4-Degrading PROTAC: Improving Druggability To Target the 'Undruggable' MYC in Pancreatic Cancer. Trends in Pharmacological Sciences. 41: 684-686. PMID 32893006 DOI: 10.1016/J.Tips.2020.08.008 |
0.492 |
|
| 2020 |
Shen AM, Minko T. Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32681948 DOI: 10.1016/J.Jconrel.2020.07.011 |
0.433 |
|
| 2019 |
Garbuzenko OB, Kuzmov A, Taratula O, Pine SR, Minko T. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy. Theranostics. 9: 8362-8376. PMID 31754402 DOI: 10.7150/Thno.39816 |
0.704 |
|
| 2019 |
Majumder J, Taratula O, Minko T. Nanocarrier-based systems for targeted and site specific therapeutic delivery. Advanced Drug Delivery Reviews. PMID 31400350 DOI: 10.1016/J.Addr.2019.07.010 |
0.698 |
|
| 2019 |
Zang X, Lee JB, Deshpande KS, Garbuzenko OB, Minko T, Kagan L. Prevention of paclitaxel-induced neuropathy by formulation approach. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30981814 DOI: 10.1016/J.Jconrel.2019.04.013 |
0.358 |
|
| 2019 |
Garbuzenko OB, Kbah N, Kuzmov A, Pogrebnyak N, Pozharov V, Minko T. Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers. Journal of Controlled Release : Official Journal of the Controlled Release Society. 296: 225-231. PMID 30677435 DOI: 10.1016/J.Jconrel.2019.01.025 |
0.396 |
|
| 2019 |
Rather GM, Anyanwu M, Kerrigan JE, Scotto KW, Garbuzenko O, Minko T, Szekely Z, Bertino JR. Abstract 5213: A modified L-penetratin peptide targeting e2f-1, 2 and 3 is effective in combination with cisplatin or pemetrexed against prostate and lung cancer cell lines Cancer Research. 79: 5213-5213. DOI: 10.1158/1538-7445.Am2019-5213 |
0.43 |
|
| 2018 |
Shaik T, Rather GM, Bansal N, Minko T, Garbuzenko O, Szekely Z, Abali EE, Banerjee D, Kerrigan JE, Scotto KW, Bertino JR. Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer. Oncotarget. 9: 33249-33257. PMID 30279956 DOI: 10.18632/Oncotarget.26064 |
0.42 |
|
| 2018 |
Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Delivery and Translational Research. 8: 1483-1507. PMID 29978332 DOI: 10.1007/S13346-018-0551-3 |
0.336 |
|
| 2018 |
Khatri P, Desai D, Shelke N, Minko T. Role of plasticizer in membrane coated extended release oral drug delivery system Journal of Drug Delivery Science and Technology. 44: 231-243. DOI: 10.1016/J.Jddst.2017.12.020 |
0.373 |
|
| 2017 |
Garbuzenko OB, Ivanova V, Kholodovych V, Reimer DC, Reuhl KR, Yurkow E, Adler D, Minko T. Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s). Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 28434932 DOI: 10.1016/J.Nano.2017.04.005 |
0.355 |
|
| 2016 |
Sapiezynski J, Taratula O, Rodriguez-Rodriguez L, Minko T. Precision targeted therapy of ovarian cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27746277 DOI: 10.1016/J.Jconrel.2016.10.014 |
0.655 |
|
| 2016 |
Li X, Taratula O, Taratula O, Schumann C, Minko T. LHRH-Targeted Drug Delivery Systems for Cancer Therapy. Mini Reviews in Medicinal Chemistry. PMID 27739358 DOI: 10.2174/1389557516666161013111155 |
0.73 |
|
| 2016 |
Savla R, Minko T. Nanoparticle design considerations for molecular imaging of apoptosis: Diagnostic, prognostic, and therapeutic value. Advanced Drug Delivery Reviews. PMID 27374457 DOI: 10.1016/J.Addr.2016.06.016 |
0.347 |
|
| 2016 |
Dorrani M, Garbuzenko OB, Minko T, Michniak-Kohn B. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 228: 150-8. PMID 26965957 DOI: 10.1016/J.Jconrel.2016.03.010 |
0.412 |
|
| 2015 |
Yin PT, Shah S, Pasquale NJ, Garbuzenko OB, Minko T, Lee KB. Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer. Biomaterials. 81: 46-57. PMID 26720500 DOI: 10.1016/J.Biomaterials.2015.11.023 |
0.368 |
|
| 2015 |
Kuzmov A, Minko T. Nanotechnology approaches for inhalation treatment of lung diseases. Journal of Controlled Release : Official Journal of the Controlled Release Society. 219: 500-18. PMID 26297206 DOI: 10.1016/J.Jconrel.2015.07.024 |
0.349 |
|
| 2015 |
Garbuzenko OB, Kuzmov A, Sapiezynski JE, Taratula O, Shah V, Zhang M, Savla R, John S, Rodriguez-Rodriguez L, Minko T. Abstract 4405: Tumor-targeted nanotherapeutics Cancer Research. 75: 4405-4405. DOI: 10.1158/1538-7445.Am2015-4405 |
0.625 |
|
| 2015 |
Shaik T, Bansal N, Farley NJ, Kerrigan J, Garbuzenko O, Minko T, Abali E, Szekely Z, Scotto K, Banerjee D, Bertino J. Abstract 1237: Antitumor studies of an E2f1 promoter sequence binding peptide - penetratin conjugate as a molecule targeting E2f in prostate cancer Cancer Research. 75: 1237-1237. DOI: 10.1158/1538-7445.Am2015-1237 |
0.418 |
|
| 2014 |
Garbuzenko OB, Winkler J, Tomassone MS, Minko T. Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs. Langmuir : the Acs Journal of Surfaces and Colloids. 30: 12941-9. PMID 25300552 DOI: 10.1021/La502144Z |
0.464 |
|
| 2014 |
Peddada LY, Garbuzenko OB, Devore DI, Minko T, Roth CM. Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes. Journal of Controlled Release : Official Journal of the Controlled Release Society. 194: 103-12. PMID 25192941 DOI: 10.1016/J.Jconrel.2014.08.023 |
0.449 |
|
| 2014 |
Savla R, Garbuzenko OB, Chen S, Rodriguez-Rodriguez L, Minko T. Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy. Pharmaceutical Research. 31: 3487-502. PMID 24919932 DOI: 10.1007/S11095-014-1436-X |
0.402 |
|
| 2014 |
Garbuzenko OB, Mainelis G, Taratula O, Minko T. Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention. Cancer Biology & Medicine. 11: 44-55. PMID 24738038 DOI: 10.7497/J.Issn.2095-3941.2014.01.004 |
0.629 |
|
| 2014 |
Xie X, Bansal N, Shaik T, Kerrigan JE, Minko T, Garbuzenko O, Abali EE, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts. Oncotarget. 5: 901-7. PMID 24658650 DOI: 10.18632/Oncotarget.1809 |
0.381 |
|
| 2014 |
Jain RN, Huang X, Das S, Silva R, Ivanova V, Minko T, Asefa T. Functionalized mesoporous silica nanoparticles for glucose- and pH-stimulated release of insulin Zeitschrift Fur Anorganische Und Allgemeine Chemie. 640: 616-623. DOI: 10.1002/Zaac.201300604 |
0.326 |
|
| 2013 |
Minko T. Nanotechnology and drug resistance. Advanced Drug Delivery Reviews. 65: 1665-6. PMID 24177352 DOI: 10.1016/J.Addr.2013.10.005 |
0.339 |
|
| 2013 |
Minko T, Rodriguez-Rodriguez L, Pozharov V. Nanotechnology approaches for personalized treatment of multidrug resistant cancers. Advanced Drug Delivery Reviews. 65: 1880-95. PMID 24120655 DOI: 10.1016/J.Addr.2013.09.017 |
0.429 |
|
| 2013 |
Shah V, Taratula O, Garbuzenko OB, Taratula OR, Rodriguez-Rodriguez L, Minko T. Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6193-204. PMID 24036854 DOI: 10.1158/1078-0432.Ccr-13-1536 |
0.702 |
|
| 2013 |
Savla R, Minko T. Nanotechnology approaches for inhalation treatment of fibrosis. Journal of Drug Targeting. 21: 914-25. PMID 23978292 DOI: 10.3109/1061186X.2013.829078 |
0.372 |
|
| 2013 |
Minko T, Hatefi A. Preface-tenth international nanomedicine and drug delivery symposium (NanoDDS'12). Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 259-60. PMID 23954371 DOI: 10.1016/J.Jconrel.2013.08.008 |
0.403 |
|
| 2013 |
Xie X, Kerrigan JE, Minko T, Garbuzenko O, Lee KC, Scarborough A, Abali EE, Budak-Alpdogan T, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer. Cancer Biology & Therapy. 14: 742-51. PMID 23792570 DOI: 10.4161/Cbt.25184 |
0.416 |
|
| 2013 |
Taratula O, Kuzmov A, Shah M, Garbuzenko OB, Minko T. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 349-57. PMID 23648833 DOI: 10.1016/J.Jconrel.2013.04.018 |
0.718 |
|
| 2013 |
Mainelis G, Seshadri S, Garbuzenko OB, Han T, Wang Z, Minko T. Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26: 345-54. PMID 23530772 DOI: 10.1089/Jamp.2011-0966 |
0.32 |
|
| 2013 |
Ivanova V, Garbuzenko OB, Reuhl KR, Reimer DC, Pozharov VP, Minko T. Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 84: 335-44. PMID 23228437 DOI: 10.1016/J.Ejpb.2012.11.023 |
0.316 |
|
| 2013 |
Shah V, Taratula O, Garbuzenko OB, Patil ML, Savla R, Zhang M, Minko T. Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids. Current Drug Discovery Technologies. 10: 8-15. PMID 22564170 DOI: 10.2174/1570163811310010003 |
0.658 |
|
| 2012 |
Hatefi A, Minko T. Advances in image-guided drug delivery. Drug Delivery and Translational Research. 2: 1-2. PMID 25786596 DOI: 10.1007/S13346-011-0057-8 |
0.371 |
|
| 2012 |
Zhang M, Garbuzenko OB, Reuhl KR, Rodriguez-Rodriguez L, Minko T. Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases. Nanomedicine (London, England). 7: 185-97. PMID 22339132 DOI: 10.2217/Nnm.11.131 |
0.365 |
|
| 2012 |
Sheihet L, Garbuzenko OB, Bushman J, Gounder MK, Minko T, Kohn J. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 45: 320-9. PMID 22155544 DOI: 10.1016/J.Ejps.2011.11.017 |
0.347 |
|
| 2012 |
Xie X, Banerjee D, Minko T, Johnson-Farley N, Kerrigan JE, Ercikan-Abali E, Scotto KW, Bertino JR. Abstract 5689: Anti-E2F-1 PEGylated liposomal encapsulated peptide regresses human small cell lung cancer & lymphoma xenografts Cancer Research. 72: 5689-5689. DOI: 10.1158/1538-7445.Am2012-5689 |
0.393 |
|
| 2011 |
Taratula O, Garbuzenko OB, Chen AM, Minko T. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. Journal of Drug Targeting. 19: 900-14. PMID 21981718 DOI: 10.3109/1061186X.2011.622404 |
0.746 |
|
| 2011 |
Betigeri S, Zhang M, Garbuzenko O, Minko T. Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage. Drug Delivery and Translational Research. 1: 13-24. PMID 21461383 DOI: 10.1007/S13346-010-0003-1 |
0.36 |
|
| 2011 |
Savla R, Taratula O, Garbuzenko O, Minko T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 153: 16-22. PMID 21342659 DOI: 10.1016/J.Jconrel.2011.02.015 |
0.695 |
|
| 2011 |
Patil ML, Zhang M, Minko T. Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing. Acs Nano. 5: 1877-87. PMID 21322531 DOI: 10.1021/Nn102711D |
0.47 |
|
| 2011 |
Taratula O, Garbuzenko O, Savla R, Wang YA, He H, Minko T. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Current Drug Delivery. 8: 59-69. PMID 21034421 DOI: 10.2174/156720111793663642 |
0.78 |
|
| 2011 |
Taratula O, Savla R, He H, Minko T. Poly(propyleneimine) dendrimers as potential siRNA delivery nanocarrier: From structure to function International Journal of Nanotechnology. 8: 36-52. DOI: 10.1504/Ijnt.2011.037169 |
0.726 |
|
| 2010 |
Christian DA, Garbuzenko OB, Minko T, Discher DE. Polymer Vesicles with a Red Cell-like Surface Charge: Microvascular Imaging and in vivo Tracking with Near-Infrared Fluorescence. Macromolecular Rapid Communications. 31: 135-41. PMID 21590885 DOI: 10.1002/Marc.200900589 |
0.344 |
|
| 2010 |
Chandna P, Khandare JJ, Ber E, Rodriguez-Rodriguez L, Minko T. Multifunctional tumor-targeted polymer-peptide-drug delivery system for treatment of primary and metastatic cancers. Pharmaceutical Research. 27: 2296-306. PMID 20700631 DOI: 10.1007/S11095-010-0235-2 |
0.468 |
|
| 2010 |
Chen AM, Taratula O, Wei D, Yen HI, Thomas T, Thomas TJ, Minko T, He H. Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes. Acs Nano. 4: 3679-88. PMID 20521827 DOI: 10.1021/Nn901796N |
0.722 |
|
| 2010 |
Garbuzenko OB, Saad M, Pozharov VP, Reuhl KR, Mainelis G, Minko T. Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proceedings of the National Academy of Sciences of the United States of America. 107: 10737-42. PMID 20498076 DOI: 10.1073/Pnas.1004604107 |
0.475 |
|
| 2010 |
Minko T, Patil ML, Zhang M, Khandare JJ, Saad M, Chandna P, Taratula O. LHRH-targeted nanoparticles for cancer therapeutics. Methods in Molecular Biology (Clifton, N.J.). 624: 281-94. PMID 20217603 DOI: 10.1007/978-1-60761-609-2_19 |
0.726 |
|
| 2010 |
Minko T. HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance. Advanced Drug Delivery Reviews. 62: 192-202. PMID 20005272 DOI: 10.1016/J.Addr.2009.12.002 |
0.434 |
|
| 2009 |
Chen AM, Zhang M, Wei D, Stueber D, Taratula O, Minko T, He H. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small (Weinheim An Der Bergstrasse, Germany). 5: 2673-7. PMID 19780069 DOI: 10.1002/Smll.200900621 |
0.725 |
|
| 2009 |
Taratula O, Garbuzenko OB, Kirkpatrick P, Pandya I, Savla R, Pozharov VP, He H, Minko T. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 140: 284-93. PMID 19567257 DOI: 10.1016/J.Jconrel.2009.06.019 |
0.765 |
|
| 2009 |
Christian DA, Cai S, Garbuzenko OB, Harada T, Zajac AL, Minko T, Discher DE. Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. Molecular Pharmaceutics. 6: 1343-52. PMID 19249859 DOI: 10.1021/Mp900022M |
0.354 |
|
| 2009 |
Patil ML, Zhang M, Taratula O, Garbuzenko OB, He H, Minko T. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules. 10: 258-66. PMID 19159248 DOI: 10.1021/Bm8009973 |
0.764 |
|
| 2009 |
Garbuzenko OB, Saad M, Betigeri S, Zhang M, Vetcher AA, Soldatenkov VA, Reimer DC, Pozharov VP, Minko T. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug. Pharmaceutical Research. 26: 382-94. PMID 18958402 DOI: 10.1007/S11095-008-9755-4 |
0.422 |
|
| 2009 |
Keresztessy Z, Bodnár M, Ber E, Hajdu I, Zhang M, Hartmann JF, Minko T, Borbély J. Self-assembling chitosan/poly-γ-glutamic acid nanoparticles for targeted drug delivery Colloid and Polymer Science. 287: 759-765. DOI: 10.1007/S00396-009-2022-3 |
0.47 |
|
| 2009 |
Taratula O, Savla R, Pandya I, Wang A, Minko T, He H. Novel superparamagnetic iron oxide nanoparticles for a multifunctional nanomedicine platform Materials Research Society Symposium Proceedings. 1140: 93-98. |
0.691 |
|
| 2009 |
Taratula O, Kirkpatrick P, Savla R, Pandya I, Minko T, He H. Surface engineering for in vivo targeting delivery of siRNA for efficient cancer therapy Materials Research Society Symposium Proceedings. 1140: 65-71. |
0.706 |
|
| 2008 |
Saad M, Garbuzenko OB, Minko T. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine (London, England). 3: 761-76. PMID 19025451 DOI: 10.2217/17435889.3.6.761 |
0.441 |
|
| 2008 |
Saad M, Garbuzenko OB, Ber E, Chandna P, Khandare JJ, Pozharov VP, Minko T. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? Journal of Controlled Release : Official Journal of the Controlled Release Society. 130: 107-14. PMID 18582982 DOI: 10.1016/J.Jconrel.2008.05.024 |
0.471 |
|
| 2008 |
Patil ML, Zhang M, Betigeri S, Taratula O, He H, Minko T. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjugate Chemistry. 19: 1396-403. PMID 18576676 DOI: 10.1021/Bc8000722 |
0.705 |
|
| 2008 |
Wang Y, Saad M, Pakunlu RI, Khandare JJ, Garbuzenko OB, Vetcher AA, Soldatenkov VA, Pozharov VP, Minko T. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3607-16. PMID 18519795 DOI: 10.1158/1078-0432.Ccr-07-2020 |
0.422 |
|
| 2008 |
Chen AM, Taratula O, Wei D, Minko T, He H. Labile catalytic packaging and delivering of short interference RNA to cancer cells: Control of gold nanoparticles "out" of siRNA complexes Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 342-345. |
0.636 |
|
| 2008 |
Taratula O, Kirkpatrick P, Savla R, Pandya I, Minko T, He H. Toward in vivo targeting delivery of siRNA for efficient cancer therapy Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 346-349. |
0.678 |
|
| 2008 |
Taratula O, Savia R, Pandya I, Geng H, Wang A, Minko T, He H. Multifunctional siRNA delivery system for cancer therapy Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 49-52. |
0.694 |
|
| 2007 |
Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, Discher DE. Shape effects of filaments versus spherical particles in flow and drug delivery. Nature Nanotechnology. 2: 249-55. PMID 18654271 DOI: 10.1038/Nnano.2007.70 |
0.356 |
|
| 2007 |
Chandna P, Saad M, Wang Y, Ber E, Khandare J, Vetcher AA, Soldatenkov VA, Minko T. Targeted proapoptotic anticancer drug delivery system. Molecular Pharmaceutics. 4: 668-78. PMID 17685579 DOI: 10.1021/Mp070053O |
0.503 |
|
| 2007 |
Zalipsky S, Saad M, Kiwan R, Ber E, Yu N, Minko T. Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: insights of the mechanism of action. Journal of Drug Targeting. 15: 518-30. PMID 17671898 DOI: 10.1080/10611860701499946 |
0.397 |
|
| 2007 |
Jayant S, Khandare JJ, Wang Y, Singh AP, Vorsa N, Minko T. Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment. Pharmaceutical Research. 24: 2120-30. PMID 17668297 DOI: 10.1007/S11095-007-9406-1 |
0.44 |
|
| 2006 |
Khandare JJ, Minko T. Antibodies and peptides in cancer therapy. Critical Reviews in Therapeutic Drug Carrier Systems. 23: 401-35. PMID 17425513 DOI: 10.1615/Critrevtherdrugcarriersyst.V23.I5.20 |
0.35 |
|
| 2006 |
Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, Minko T. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjugate Chemistry. 17: 1464-72. PMID 17105225 DOI: 10.1021/Bc060240P |
0.413 |
|
| 2006 |
Minko T, Pakunlu RI, Wang Y, Khandare JJ, Saad M. New generation of liposomal drugs for cancer. Anti-Cancer Agents in Medicinal Chemistry. 6: 537-52. PMID 17100558 DOI: 10.2174/187152006778699095 |
0.491 |
|
| 2006 |
Ahmed F, Pakunlu RI, Brannan A, Bates F, Minko T, Discher DE. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. Journal of Controlled Release : Official Journal of the Controlled Release Society. 116: 150-8. PMID 16942814 DOI: 10.1016/J.Jconrel.2006.07.012 |
0.435 |
|
| 2006 |
Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. Journal of Controlled Release : Official Journal of the Controlled Release Society. 114: 153-62. PMID 16889867 DOI: 10.1016/J.Jconrel.2006.06.010 |
0.502 |
|
| 2006 |
Betigeri S, Pakunlu RI, Wang Y, Khandare JJ, Minko T. JNK1 as a molecular target to limit cellular mortality under hypoxia. Molecular Pharmaceutics. 3: 424-30. PMID 16889436 DOI: 10.1021/Mp060014X |
0.348 |
|
| 2006 |
Ahmed F, Pakunlu RI, Srinivas G, Brannan A, Bates F, Klein ML, Minko T, Discher DE. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Molecular Pharmaceutics. 3: 340-50. PMID 16749866 DOI: 10.1021/Mp050103U |
0.415 |
|
| 2006 |
Khandare JJ, Chandna P, Wang Y, Pozharov VP, Minko T. Novel polymeric prodrug with multivalent components for cancer therapy. The Journal of Pharmacology and Experimental Therapeutics. 317: 929-37. PMID 16469865 DOI: 10.1124/Jpet.105.098855 |
0.499 |
|
| 2006 |
Dharap SS, Chandna P, Wang Y, Khandare JJ, Qiu B, Stein S, Minko T. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy. The Journal of Pharmacology and Experimental Therapeutics. 316: 992-8. PMID 16291730 DOI: 10.1124/Jpet.105.094243 |
0.44 |
|
| 2006 |
Khandare J, Minko T. Polymer-drug conjugates: Progress in polymeric prodrugs Progress in Polymer Science (Oxford). 31: 359-397. DOI: 10.1016/J.Progpolymsci.2005.09.004 |
0.382 |
|
| 2005 |
Minko T. Soluble polymer conjugates for drug delivery. Drug Discovery Today. Technologies. 2: 15-20. PMID 24981750 DOI: 10.1016/J.Ddtec.2005.05.005 |
0.429 |
|
| 2005 |
Yu D, Peng P, Dharap SS, Wang Y, Mehlig M, Chandna P, Zhao H, Filpula D, Yang K, Borowski V, Borchard G, Zhang Z, Minko T. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 110: 90-102. PMID 16271793 DOI: 10.1016/J.Jconrel.2005.09.050 |
0.445 |
|
| 2005 |
Minko T, Wang Y, Pozharov V. Remediation of cellular hypoxic damage by pharmacological agents. Current Pharmaceutical Design. 11: 3185-99. PMID 16178753 DOI: 10.2174/1381612054864948 |
0.337 |
|
| 2005 |
Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, Gunaseelan S, Sinko PJ, Stein S, Farmanfarmaian A, Minko T. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide Proceedings of the National Academy of Sciences of the United States of America. 102: 12962-12967. PMID 16123131 DOI: 10.1073/Pnas.0504274102 |
0.527 |
|
| 2005 |
Minko T, Batrakova EV, Li S, Li Y, Pakunlu RI, Alakhov VY, Kabanov AV. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 105: 269-78. PMID 15939500 DOI: 10.1016/J.Jconrel.2005.03.019 |
0.42 |
|
| 2004 |
Wang Y, Pakunlu RI, Tsao W, Pozharov V, Minko T. Bimodal effect of hypoxia in cancer: role of hypoxia inducible factor in apoptosis. Molecular Pharmaceutics. 1: 156-65. PMID 15832512 DOI: 10.1021/Mp034031N |
0.353 |
|
| 2004 |
Wang Y, Minko T. A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug. Biochemical Pharmacology. 68: 2031-42. PMID 15476674 DOI: 10.1016/J.Bcp.2004.07.017 |
0.408 |
|
| 2004 |
Pakunlu RI, Wang Y, Tsao W, Pozharov V, Cook TJ, Minko T. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system. Cancer Research. 64: 6214-24. PMID 15342407 DOI: 10.1158/0008-5472.Can-04-0001 |
0.468 |
|
| 2004 |
Minko T, Dharap SS, Pakunlu RI, Wang Y. Molecular targeting of drug delivery systems to cancer Current Drug Targets. 5: 389-406. PMID 15134222 DOI: 10.2174/1389450043345443 |
0.468 |
|
| 2004 |
Minko T. Drug targeting to the colon with lectins and neoglycoconjugates. Advanced Drug Delivery Reviews. 56: 491-509. PMID 14969755 DOI: 10.1016/J.Addr.2003.10.017 |
0.472 |
|
| 2004 |
David A, Kopecková P, Minko T, Rubinstein A, Kopecek J. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. European Journal of Cancer (Oxford, England : 1990). 40: 148-57. PMID 14687799 DOI: 10.1016/J.Ejca.2003.07.001 |
0.488 |
|
| 2003 |
Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. Journal of Controlled Release : Official Journal of the Controlled Release Society. 91: 61-73. PMID 12932638 DOI: 10.1016/S0168-3659(03)00209-8 |
0.497 |
|
| 2003 |
Dharap SS, Minko T. Targeted proapoptotic LHRH-BH3 peptide. Pharmaceutical Research. 20: 889-96. PMID 12817893 DOI: 10.1023/A:1023839319950 |
0.353 |
|
| 2003 |
Minko T, Dharap SS, Fabbricatore AT. Enhancing the efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular defense. Cancer Detection and Prevention. 27: 193-202. PMID 12787726 DOI: 10.1016/S0361-090X(03)00067-9 |
0.415 |
|
| 2003 |
Peterson CM, Shiah JG, Sun Y, Kopecková P, Minko T, Straight RC, Kopecek J. HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer. Advances in Experimental Medicine and Biology. 519: 101-23. PMID 12675211 DOI: 10.1007/0-306-47932-X_7 |
0.479 |
|
| 2003 |
Pakunlu RI, Cook TJ, Minko T. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin. Pharmaceutical Research. 20: 351-9. PMID 12669953 DOI: 10.1023/A:1022687617318 |
0.395 |
|
| 2002 |
Minko T, Paranjpe PV, Qiu B, Lalloo A, Won R, Stein S, Sinko PJ. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 50: 143-50. PMID 12172980 DOI: 10.1007/S00280-002-0463-1 |
0.462 |
|
| 2001 |
Kasuya Y, Lu ZR, Kopečková P, Minko T, Tabibi SE, Kopeček J. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates Journal of Controlled Release. 74: 203-211. PMID 11489496 DOI: 10.1016/S0168-3659(01)00318-2 |
0.37 |
|
| 2001 |
Kopeček J, Kopečková P, Minko T, Lu ZR, Peterson CM. Water soluble polymers in tumor targeted delivery Journal of Controlled Release. 74: 147-158. PMID 11489491 DOI: 10.1016/S0168-3659(01)00330-3 |
0.418 |
|
| 2001 |
Minko T, Kopečková P, Kopeček J. Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin Macromolecular Symposia. 172: 35-48. DOI: 10.1002/1521-3900(200107)172:1<35::Aid-Masy35>3.0.Co;2-N |
0.378 |
|
| 2001 |
Minko T, Kopekov P, Kopeek J. Immunoprotective therapy with targeted anticancer drugs Macromolecular Symposia. 172: 21-28. DOI: 10.1002/1521-3900(200107)172:1<21::AID-MASY21>3.0.CO;2-C |
0.319 |
|
| 2001 |
Minko T, Dharap SS, Pakunlu RI, Colaizzi JL. Advanced drug delivery systems in cancer chemotherapy Disease Management and Clinical Outcomes. 3: 48-54. |
0.363 |
|
| 2000 |
Wang D, Kopečková P, Minko T, Nanayakkara V, Kopeček J. Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: Potential drug carriers Biomacromolecules. 1: 313-319. PMID 11710118 DOI: 10.1021/Bm0000236 |
0.369 |
|
| 2000 |
Demoy M, Minko T, Kopečková P, Kopeček J. Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells Journal of Controlled Release. 69: 185-196. PMID 11018556 DOI: 10.1016/S0168-3659(00)00301-1 |
0.354 |
|
| 2000 |
Kopeček J, Kopečková P, Minko T, Lu ZR. HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action European Journal of Pharmaceutics and Biopharmaceutics. 50: 61-81. PMID 10840193 DOI: 10.1016/S0939-6411(00)00075-8 |
0.447 |
|
| 2000 |
Minko T, Kopečková P, Kopeček J. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma International Journal of Cancer. 86: 108-117. PMID 10728603 DOI: 10.1002/(Sici)1097-0215(20000401)86:1<108::Aid-Ijc17>3.0.Co;2-8 |
0.35 |
|
| 2000 |
Kunath K, Kopečková P, Minko T, Kopeček J. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound Adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line European Journal of Pharmaceutics and Biopharmaceutics. 49: 11-15. PMID 10613922 DOI: 10.1016/S0939-6411(99)00033-8 |
0.347 |
|
| 1999 |
Minko T, Kopečková P, Kopeček J. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells Pharmaceutical Research. 16: 986-996. PMID 10450921 DOI: 10.1023/A:1018959029186 |
0.352 |
|
| 1999 |
Choi WM, Kopečková P, Minko T, Kopeček J. Synthesis of HPMA copolymer containing adriamycin bound via an acid- labile spacer and its activity toward human ovarian carcinoma cells Journal of Bioactive and Compatible Polymers. 14: 447-456. DOI: 10.1177/088391159901400601 |
0.319 |
|
| Show low-probability matches. |